132 related articles for article (PubMed ID: 3181045)
1. [Hypercholesterolemia and the diagnosis and management of hyper- lipidemia in adults. Recommendations of the working groups of the Finnish Society of Internal Medicine and the Finnish Cardiology Society].
Duodecim; 1988; 104(18):1425-38. PubMed ID: 3181045
[No Abstract] [Full Text] [Related]
2. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.
Fodor JG; Frohlich JJ; Genest JJ; McPherson PR
CMAJ; 2000 May; 162(10):1441-7. PubMed ID: 10834048
[No Abstract] [Full Text] [Related]
3. Diagnosis and management of hyperlipidemia.
Palumbo PJ
Compr Ther; 1978 Oct; 4(10):33-9. PubMed ID: 359229
[No Abstract] [Full Text] [Related]
4. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
[No Abstract] [Full Text] [Related]
5. [Diagnosis and treatment of hypercholesterolemia and other and hyperlipidemias in the year 1992. Finnish Associations of Internists, Cardiologists, Heart Diseases, Community Physicians, and the Committee of Industrial Medicine].
Duodecim; 1993; 109(6):481-501. PubMed ID: 8062717
[No Abstract] [Full Text] [Related]
6. Drug therapy for hyperlipidemia.
Franklin FA; Margolis S
Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
[No Abstract] [Full Text] [Related]
7. Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada.
Frohlich J; Fodor G; McPherson R; Genest J; Langner N
Can J Cardiol; 1998 Apr; 14 Suppl A():17A-21A. PubMed ID: 9594929
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis of the American Heart Association.
Arteriosclerosis; 1984; 4(4):443A-468A. PubMed ID: 6466199
[No Abstract] [Full Text] [Related]
9. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Tapounet R; Marti Ragué I
Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931
[TBL] [Abstract][Full Text] [Related]
10. Hyperlipoproteinemias in the prematurely aged. Theories of pathogenesis, diagnosis, classification, and treatment.
Herrmann GR
Geriatrics; 1970 Apr; 25(4):103-14. PubMed ID: 5443794
[No Abstract] [Full Text] [Related]
11. [Drug therapy of dyslipidemias].
Fonda M; Cattin L; Guarnieri G
Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
[No Abstract] [Full Text] [Related]
12. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin].
Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh
Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147
[TBL] [Abstract][Full Text] [Related]
13. [What should be the role of antilipemic agents in the control of hypercholesterolemia in elderly persons?].
Champoux N; Latour J
Union Med Can; 1994 Feb; 123(2):91-4. PubMed ID: 8203037
[No Abstract] [Full Text] [Related]
14. [Clinical trial of tibric acid, a new hypolipidemic agent].
Noseda G; Sirtori CR
Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
[No Abstract] [Full Text] [Related]
15. [Clinical trials with Fonlipol. Apropos of 50 cases].
Warembourg H; Jaillard J
Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
[No Abstract] [Full Text] [Related]
16. [Controversies and advances in the treatment of hyperlipidemias].
Reza-Albarrán A; Aguilar-Salinas CA
Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
[No Abstract] [Full Text] [Related]
17. [High cholesterol levels are discriminated by new therapeutic recommendations].
Olsson AG
Lakartidningen; 2000 Apr; 97(16):1995-6. PubMed ID: 10826361
[No Abstract] [Full Text] [Related]
18. [Classification of hyperlipoproteinemias].
Zabel R
Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507
[No Abstract] [Full Text] [Related]
19. Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholesterolemia.
Weisweiler P
Arzneimittelforschung; 1988 Jul; 38(7):925-7. PubMed ID: 3207437
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of hypolipemic action of the preparation olbetam in people with primary hypercholesterolemia].
Miturzyńska-Stryjecka H; Widomska-Czekajska T; Bielak G; Grossmann G
Wiad Lek; 1994 Aug; 47(15-16):566-9. PubMed ID: 7716950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
